Tag: sp:iveric bio
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal...
– IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across...
Detecting Geographic Atrophy is in Optometry’s Wheelhouse
Optical coherence tomography (OCT) is a great, non-invasive imaging modality that many ODs are using in their practices. However, OCTs are often ordered only...
Imaging Guide: A Deeper Dive Into Geographic Atrophy
A comprehensive eye examination with imaging can help with early
detection, diagnosis, and monitoring of the progression of age-related
macular degeneration (AMD) to geographic atrophy.1,2 To...
You’ve Identified a GA Patient. Now What?
Early detection of geographic atrophy (GA) and timely referral may help maintain the quality of vision patients deserve for longer.1
Iveric Bio has developed a...
How Are You Managing Patients With Geographic Atrophy?
Geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD), is defined by the presence of sharply demarcated atrophic lesions of the...
Geographic Atrophy By the Numbers
About 1.5 million people in the U.S. are affected by geographic atrophy (GA), according to data presented in factsheet from Iveric Bio: Geographic Dystrophy...
Geographic Atrophy: The Importance of Imaging
Imaging is critical to the detection and monitoring of geographic atrophy (GA). In The Importance of Imaging, SriniVas Sadda, MD, talks with Eric Donnefeld,...
Doctors Discuss Myths Surrounding Geographic Atrophy
Key myths and misconceptions about geographic atrophy (GA) exist, even in the provider community. In a six-minute video titled, Dismiss the Myths, four doctors...
